The Vanguard Group 13D and 13G filings for Capricor Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-30 10:58 am Sale |
2025-03-31 | 13G | Capricor Therapeutics, Inc. CAPR |
The Vanguard Group | 2,263,991 4.950% |
-12,793 (-0.56%) |
Filing |
| 2025-01-30 9:34 pm Purchase |
2024-12-31 | 13G | Capricor Therapeutics, Inc. CAPR |
The Vanguard Group | 2,276,784 5.000% |
2,276,784 (New Position) |
Filing |